← Wiki Index / Microbiology & Immunology / T-Cell Cross-Dressing
🦠 Microbiology & Immunology

T-Cell Cross-Dressing

T-Cell Cross-Dressing (and dendritic cell cross-dressing) is a non-canonical antigen presentation pathway in which recipient immune cells acquire intact, preformed peptide–MHC complexes directly from the membranes of donor cells without intracellular antigen processing.

T-Cell Cross-Dressing (more broadly termed MHC cross-dressing across dendritic cells and T lymphocytes) is a non-canonical pathway of adaptive antigen presentation in which an immune cell—either a recipient dendritic cell (DC) or an activated T lymphocyte—acquires intact, already folded peptide–major histocompatibility complex (pMHC class I or pMHC class II) molecules directly from the plasma membrane of a donor cell and displays them on its own surface to prime or regulate other T cells. Coined as "cross-dressing" in 2005–2006 (Dolan et al., 2006) to distinguish it from classical cross-presentation, cross-dressing bypasses intracellular antigen uptake, proteasomal cleavage, TAP transport, and endoplasmic reticulum peptide loading. Transferred via contact-dependent trogocytosis, tunneling nanotubes, or extracellular vesicles (exosomes), cross-dressed pMHC complexes play central roles in antiviral and antitumor CD8+ T-cell priming, maternal–fetal tolerance, and allograft rejection after organ transplantation.

Mechanistic Distinction from Direct and Cross-Presentation

To activate naive or memory CD8+ and CD4+ T lymphocytes—which in inflammatory settings may also undergo cytokine-driven bystander T-cell activation—antigen-presenting cells (APCs) utilize three distinct pathways to display antigenic peptides bound to MHC molecules:

  1. Direct Presentation: A virus-infected cell or donor APC synthesizes proteins endogenously, degrades them via the cytosolic proteasome, imports 8–10-mer peptides via TAP1/TAP2 into the endoplasmic reticulum (ER), loads them onto self MHC class I molecules, and exports the pMHC-I complex to its plasma membrane (or loads endocytosed antigens onto self MHC-II in endolysosomes).
  2. Canonical Cross-Presentation: An uninfected host conventional type 1 dendritic cell (cDC1, expressing XCR1 and CLEC9A) phagocytoses apoptotic virus-infected or tumor cell debris, exports protein antigens from the phagosome into the cytosol, cleaves them into peptides via its own proteasome, and loads those peptides onto its own newly synthesized self MHC-I molecules.
  3. Cross-Dressing (Preformed pMHC Transfer): An uninfected recipient dendritic cell or T cell snatches preformed, peptide-loaded donor MHC-I or MHC-II complexes directly from the membrane of a donor cell and inserts the intact membrane patch into its own plasma membrane without proteolytic cleavage or TAP-dependent reloading.
FeatureDirect Antigen PresentationCanonical Cross-PresentationCross-Dressing (Preformed pMHC Transfer)
Origin of MHC MoleculeEndogenous self MHC of infected/donor cellEndogenous self MHC of recipient cDC1Donor cell MHC transferred intact to recipient cell
Proteasome & TAP1/TAP2 Required in Recipient?Required in donor/infected cellRequired in recipient DC (cytosolic pathway)Not required in recipient cell (pre-loaded on donor)
Peptide Epitope RepertoireFull endogenous proteasome + immunoproteasomeSkewed toward long-lived stable protein substratesPreserves native donor proteasome/peptide repertoire
Membrane Transfer MechanismIntracellular vesicular secretory trafficPhagocytosis / macropinocytosis of cell corpsesTrogocytosis, exosomes, tunneling nanotubes
Allogeneic Transplant RecognitionDirect pathway (donor passenger APCs)Indirect pathway (donor peptide on host MHC)Semi-direct pathway (intact donor pMHC on host DC)

Cellular Conduits: Trogocytosis and Extracellular Vesicles

Contact-Dependent Trogocytosis at the Immunological Synapse

When an antigen-specific CD8+ or CD4+ T cell forms a tight immunological synapse with an antigen-presenting cell—or when a resident lymphoid dendritic cell contacts a migrating peripheral DC or tumor cell—high-avidity receptor–ligand binding (TCR–pMHC and LFA-1–ICAM-1) triggers trogocytosis (from the Greek trogo, "to gnaw"). Driven by actin-cytoskeletal remodeling, the recipient cell physically extracts nanoscale membrane fragments (50–500 nm across) from the donor cell surface within minutes of conjugate formation.

As a result, the recipient T cell or DC becomes "cross-dressed" with functional donor pMHC-I, pMHC-II, and costimulatory ligands (CD80, CD86, OX40L, PD-L1) in the correct inside-out transmembrane topology. When a CD8+ T cell acquires pMHC-I complexes from an APC via TCR-mediated trogocytosis, it temporarily becomes an antigen-presenting T cell capable of stimulating neighboring T cells, though it also becomes susceptible to fratricide (lysis by sibling cytotoxic T lymphocytes recognizing the acquired pMHC-I).

Exosomes and Tunneling Nanotubes

In addition to direct cell–cell contact, donor tumor cells, virus-infected epithelial cells, and vascular endothelial cells release 30–150 nm extracellular vesicles (exosomes) derived from multivesicular endosomes that are densely studded with preformed pMHC-I and pMHC-II complexes alongside tetraspanins (CD9, CD63, CD81) and ICAM-1. When lymph-node-resident dendritic cells capture these exosomes via LFA-1 or phosphatidylserine receptors (TIM-4, MFG-E8), the vesicles fuse or stay tethered on the DC plasma membrane, allowing the recipient DC to present donor pMHC complexes alongside its own robust CD80/CD86 costimulation and IL-12 cytokines—representing a mammalian intercellular sharing mechanism analogous in cooperative architecture to microbial extracellular electron transfer and syntrophy.

Roles in Antiviral Immunity, Cancer, and Transplantation

Antiviral and Antitumor CD8+ T-Cell Priming

In 2011, Wakim and Bevan demonstrated using bone-marrow chimeric mice bearing mutated MHC-I molecules incapable of direct TCR contact that during vesicular stomatitis virus (VSV) and lymphocytic choriomeningitis virus (LCMV) infection, lymph-node DCs cross-dressed with preformed viral pMHC-I complexes drive rapid expansion of memory CD8+ T cells without requiring TAP1 or proteasomal processing inside the DC. In 2022, MacNabb et al. and Duong et al. further showed that in solid tumors, conventional cDC1 and cDC2 subsets acquire intact tumor-derived pMHC-I complexes via cross-dressing and that this pathway is sufficient—and in several tumor models required—to prime antitumor CD8+ T cells when canonical phagocytic cross-presentation is inefficient.

The Semi-Direct Pathway of Allograft Rejection

In clinical organ transplantation (kidney, heart, liver, and hematopoietic stem cell grafts), classical immunology divided T-cell allorecognition into the direct pathway (host T cells recognizing intact donor MHC on short-lived donor "passenger leukocytes") and the indirect pathway (host DCs processing shed donor MHC proteins into peptides presented on host MHC-II). In 2004, Robert Lechler and colleagues defined the semi-direct pathway, wherein long-lived host dendritic cells infiltrate the graft, cross-dress with intact donor pMHC-I and pMHC-II molecules from graft endothelial and parenchymal cells, and migrate to secondary lymphoid organs. Studies between 2016 and 2020 (Marino et al.; Hughes et al.) proved that donor passenger leukocytes die within days of transplantation and that host DCs cross-dressed with intact donor MHC are the primary drivers of acute and chronic T-cell-mediated allograft rejection.

Frequently Asked Questions

Why does cross-dressing preserve tumor and viral neoantigens that canonical cross-presentation misses?

Tumor cells and virus-infected cells often express specialized proteasome subunits (such as the standard house-keeping proteasome vs. the IFN-γ-inducible immunoproteasome inside cDC1s) and generate short-lived defective ribosomal products (DRiPs) that are rapidly loaded onto MHC-I inside the tumor cell ER but are degraded before they can survive phagocytosis and cytosolic export during canonical cross-presentation. Because cross-dressing transfers the already assembled pMHC-I complex directly from the tumor cell membrane onto the host DC, the recipient DC displays the exact peptide repertoire present on the tumor cell target, avoiding epitope mismatch between priming DCs and target tumor cells.

How can T-cell cross-dressing induce immune tolerance or fratricide?

When an activated effector CD8+ T cell strips high densities of cognate pMHC-I from an antigen-presenting cell via trogocytosis, neighboring cytotoxic CD8+ T cells recognize the cross-dressed T cell as an infected target and kill it via perforin/granzyme B (T-cell fratricide), serving as a negative-feedback brake on clonal expansion. Furthermore, if quiescent dendritic cells or regulatory T cells (Tregs) cross-dress with pMHC complexes in the absence of CD80/CD86 costimulation or simultaneously acquire PD-L1 from donor cells, they induce T-cell anergy or clonal deletion.

References

  1. Dolan, B. P., Gibbs, K. D., Jr., & Ostrand-Rosenberg, S. (2006). "Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells." The Journal of Immunology, 177(9), 6018–6024. https://doi.org/10.4049/jimmunol.177.9.6018
  2. Wakim, L. M., & Bevan, M. J. (2011). "Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection." Nature, 471(7340), 629–632. https://doi.org/10.1038/nature09863
  3. Marino, J., Babiker-Mohamed, M. H., Crosby-Bertorini, P., et al. (2016). "Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation." Science Immunology, 1(1), aaf8759. https://doi.org/10.1126/sciimmunol.aaf8759
  4. Duong, E., Fessenden, T. B., Lutz, E., et al. (2022). "Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity." Immunity, 55(2), 308–323. https://doi.org/10.1016/j.immuni.2021.10.020
🧬 Support Open Science
Explore interactive science games on LowKey Games or browse scientific apparel & accessories in the CRV Science Shop.
💡 Spot an inaccuracy or have primary literature to expand this article?
Submit a citation or revision note using your shared CRV Science / LowKey Games profile ID.
Suggest Revision